companydata.dkcompanydata.dk

LIPLASOME PHARMA ApS: Financial statements 2012

CVR: 29428514

Source: annual report 2012, Danish Business Authority

01/01/201231/12/2012

LIPLASOME PHARMA ApS (CVR 29428514) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -850,000 and a net result of DKK -3,002,000. Equity in the 2012 report amounted to DKK 19,741,000. The solvency ratio was 95.9%. The company had 2 employees in the financial year.

Gross Profit
DKK -850,000
Profit/Loss
DKK -3,002,000
Equity
DKK 19,741,000
Total Assets
DKK 20,587,000
Employees
2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on LIPLASOME PHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2012

Hans-Henrik Horsted Eriksen joins the board of LIPLASOME PHARMA ApSAug 24, 2012

As of August 24, 2012, Hans-Henrik Horsted Eriksen has joined the board of directors of LIPLASOME PHARMA ApS.

John Riis Mortensen joins the board of LIPLASOME PHARMA ApSAug 24, 2012

As of August 24, 2012, John Riis Mortensen has joined the board of directors of LIPLASOME PHARMA ApS.

Duncan Moore joins the board of LIPLASOME PHARMA ApSAug 24, 2012

As of August 24, 2012, Duncan Moore has joined the board of directors of LIPLASOME PHARMA ApS.

Torben Brøgger-Mikkelsen leaves the board of LIPLASOME PHARMA ApSAug 24, 2012

As of August 24, 2012, Torben Brøgger-Mikkelsen has left the board of directors of LIPLASOME PHARMA ApS.

Holger Bagger-Sørensen leaves the board of LIPLASOME PHARMA ApSAug 24, 2012

As of August 24, 2012, Holger Bagger-Sørensen has left the board of directors of LIPLASOME PHARMA ApS.

Torben Vilsgaard leaves the board of LIPLASOME PHARMA ApSAug 24, 2012

As of August 24, 2012, Torben Vilsgaard has left the board of directors of LIPLASOME PHARMA ApS.

Steen Bagger-Sørensen leaves the board of LIPLASOME PHARMA ApSAug 24, 2012

As of August 24, 2012, Steen Bagger-Sørensen has left the board of directors of LIPLASOME PHARMA ApS.

Claus Bagger-Sørensen leaves the board of LIPLASOME PHARMA ApSAug 24, 2012

As of August 24, 2012, Claus Bagger-Sørensen has left the board of directors of LIPLASOME PHARMA ApS.

Hans-Henrik Horsted Eriksen joins LIPLASOME PHARMA ApS as adm. dir.Aug 24, 2012

As of August 24, 2012, Hans-Henrik Horsted Eriksen is registered as adm. dir. of LIPLASOME PHARMA ApS.

About LIPLASOME PHARMA ApS

LIPLASOME PHARMA ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans-Henrik Horsted Eriksen. The board consists of John Riis Mortensen (chair), Hans-Henrik Horsted Eriksen and Sanjay Kumar Sehgal. The company is owned by BAGGER-SØRENSEN & CO. A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -28,000 and a net result of DKK 62,000 compared with DKK -36,000 the year before. Equity in the 2025 report amounted to DKK 2,377,000.

Source: annual report 2025, Danish Business Authority